Neumonía intersticial con características autoinmunes (IPAF): reporte de casos
Resumen
IPAF agrupa individuos con EPID y otras características clínicas, serológicas o pulmonares que derivan de una condición autoinmune sistémica subyacente, pero no cumplen con los criterios reumatológicos actuales para una ETC. La EPID, manifestación clínica frecuente de las ETC, puede aparecer en el contexto de una ETC conocida pero no es infrecuente que sea la primera y única manifestación de un ETC oculta. Identificar una ETC subyacente en pacientes que presentan con compromiso intersticial inicial puede ser un desafío; tales evaluaciones pueden optimizarse mediante un enfoque multidisciplinario. Presentamos el caso de tres pacientes, de diferente presentación, evolución y tratamiento, todos caracterizados hasta la fecha como IPAF.Citas
I. Fischer A, Antoniou K, Brown K. An official European Respiratory Society/ American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46:976–987 | DOI: 10.1183/13993003.00150-2015.
II. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788–824.
III. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. AmJ Respir Crit Care Med 2013.
IV. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165:277–304.
V. Solomon J, Chartrand S, Fischer A. Current approach to connective tissue disease-associated interstitial lung disease. Curr Opin Pulm Med 2014; 20: 449–456.
VI. Cottin, V. Interstitial pneumonia with CTD features. Respirology, 21: 245-258. doi:10.1111/resp.12588.
VII. Fernandes L, Nasser M, Ahmad K, et al. “Interstitial Pneumonia With Autoimmune Features (IPAF).” Frontiers in medicine vol. 6 209. 27 Sep. 2019, doi:10.3389/fmed.2019.00209.
VIII. Ahmad K, Barba T, Gamondes D, et al. Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med. (2017) 123:56–62. doi: 10.1016/j.rmed.2016.10.017.
IX. Chartrand S, Swigris J, Stanchev L, et al. Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience. RespirMed. (2016) 119:150–4. doi: 10.1016/j.rmed.2016.09.002.
X. Oldham J, Adegunsoye A, Valenzi E, et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. (2016) 47:1767–75. doi: 10.1183/13993003.0156 5-2015.
XI. Sambataro G, Sambataro D, Torrisi S, et al. State of the art in Interstitial Pneumonia with Autoimmune Features (IPAF): a systematic review on retrospective studies and suggestion for further advances, Eur. Respir. Rev. 27 (2018) pii 170139 https://doi. org/10.1183/16000617.0139-2017.
XII. Cottin V. Interstitial lung disease: are we missing formes frustes of connective tissue disease? Eur Respir J. (2006) 28:893–6. doi: 10.1183/09031936.00101506.
XIII. Wells A, Devaraj A, Renzoni E, Dentonet C, et al. Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease. En Seminars in respiratory and critical care
medicine. Thieme Medical Publishers, 2019. p. 184-193.
XIV. Kelly B, MouaT. Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality. Respirology. (2018) 23:600–5. doi:
1111/resp.13254.
XV. Aliberti S, Masefield S, Polverino E, et al. Research Priorities in Bronchiectasis: A Consensus Statement From the EMBARC Clinical Research Collaboration. Eur Respir J. 2016 Sep; 48(3):632-47. doi: 10.1183/13993003.01888-2015.
XVI. Sambataro G, Sambataro D, Torrisi S, et al. Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients. Respiratory medicine 150:154-160, April 2019. DOI: 10.1016/j.rmed.2019.03.011.
XVII. Mathai S, Danoff S. Management of Interstitial Lung Disease Associated With Connective Tissue Disease. BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819.
XVIII. Suzuki A, Kondoh Y, Fischer A. Recent Advances in Connective Tissue Disease Related Interstitial Lung Disease. Expert Rev Respir Med . 2017 Jul;11(7):591-603. doi: 10.1080/17476348.2017.1335600. Epub 2017 Jun 2.
Derechos de autor 2021 A nombre de los autores. Derechos de reproducción: Sociedad Argentina de Reumatología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
